blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1305017

EP1305017 - METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SYNDROME X [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.07.2006
Database last updated on 02.11.2024
Most recent event   Tooltip21.07.2006Application deemed to be withdrawnpublished on 23.08.2006  [2006/34]
Applicant(s)For all designated states
Pharmanutrients
918 Sherwood Drive
Lake Bluff, IL 60044 / US
[2003/18]
Inventor(s)01 / MENARD, Michael
7488 Bittersweet Drive
Gurnee, IL 60031 / US
02 / ROCKWAY, Susie
186 Main Sail Drive
Grayslake, IL 60030 / US
 [2003/18]
Representative(s)Becker Kurig & Partner Patentanwälte mbB
Bavariastraße 7
80336 München / DE
[N/P]
Former [2003/18]Becker Kurig Straus
Patentanwälte Bavariastrasse 7
80336 München / DE
Application number, filing date00952398.602.08.2000
[2003/18]
WO2000US21044
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0209691
Date:07.02.2002
Language:EN
[2002/06]
Type: A1 Application with search report 
No.:EP1305017
Date:02.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 07.02.2002 takes the place of the publication of the European patent application.
[2003/18]
Search report(s)International search report - published on:US07.02.2002
(Supplementary) European search report - dispatched on:EP03.12.2003
ClassificationIPC:A61K31/20
[2003/18]
CPC:
A61K31/201 (EP,US); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P5/48 (EP); A61P9/10 (EP);
A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2003/18]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNG ZUR VORBEUGUNG UND BEHANDLUNG VON SYNDROM X[2003/18]
English:METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SYNDROME X[2003/18]
French:PROCEDES ET COMPOSITIONS POUR LA PREVENTION ET LE TRAITEMENT DU SYNDROME X[2003/18]
Entry into regional phase28.01.2003National basic fee paid 
28.01.2003Search fee paid 
28.01.2003Designation fee(s) paid 
28.01.2003Examination fee paid 
Examination procedure19.02.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
28.01.2003Examination requested  [2003/18]
18.10.2005Despatch of a communication from the examining division (Time limit: M04)
01.03.2006Application deemed to be withdrawn, date of legal effect  [2006/34]
06.04.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/34]
Fees paidRenewal fee
08.04.2003Renewal fee patent year 03
11.09.2003Renewal fee patent year 04
31.08.2004Renewal fee patent year 05
31.08.2005Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
02.03.200303   M06   Fee paid on   08.04.2003
31.08.200304   M06   Fee paid on   11.09.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0843972  (NUTRICIA NV [NL]) [X] 1-16 * page 2, line 39 - page 3, line 24; claim - *;
 [X]WO9900116  (YISSUM RES DEV CO [IL]) [X] 1-16 * the whole document *;
 [A]  - HOUSEKNECHT K L ET AL, "DIETARY CONJUGATED LINOLEIC ACID NORMALIZES IMPAIRED GLUCOSE TOLERANCE IN THE ZUCKER DIABETIC FATTY FA/FA RAT", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (19980327), vol. 244, no. 3, ISSN 0006-291X, pages 678 - 682, XP001084293 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1006/bbrc.1998.8303
 [A]  - SIMOPOULOS A P, "IS INSULIN RESISTANCE INFLUENCED BY DIETARY LINOLEIC ACID AND TRANS FATTY ACIDS?", FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE, XX, (19941001), vol. 17, no. 4, ISSN 0891-5849, pages 367 - 372, XP000671190 [A] 1-16 * page 369, column R, line 19 - page 371, column L, line 13 *

DOI:   http://dx.doi.org/10.1016/0891-5849(94)90023-X
 [A]  - YAM, D. ET AL., "Diet and disease - The Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet", ISRAEL JOURNAL OF MEDICAL SCIENCES, (199611), vol. 32, no. 11, pages 1134 - 1143, XP009021729 [A] 1-16 * page 1135, column R, line 6 - page 1136, column R, line 23 * * page 1140, column L, lines 32-40 *
International search[A]US5886037  (KLOR HANS-ULRICH BERNHARD [DE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.